EP2429542 - PREVENTION AND TREATMENT OF ALLERGIC DIARRHOEA [Right-click to bookmark this link] | Status | The application has been refused Status updated on 21.01.2022 Database last updated on 22.11.2024 | Most recent event Tooltip | 21.01.2022 | Refusal of application | published on 23.02.2022 [2022/08] | Applicant(s) | For all designated states Société des Produits Nestlé S.A. Entre-deux-Villes 1800 Vevey / CH | [2019/28] |
Former [2012/12] | For all designated states Nestec S.A. Avenue Nestlé 55 1800 Vevey / CH | Inventor(s) | 01 /
NUTTEN, Sophie Av. de l'Avant Poste 3 CH-Lausanne 1005 / CH | 02 /
MERCENIER, Annick Ch. de Rente 10 CH-1030 Bussigny / CH | 03 /
DUNCKER, Swantje Avenue de Bethusy 84 CH-1012 Lausanne / CH | [2012/12] | Representative(s) | Lomholt, Stig Bredsted Société des Produits Nestlé S.A. Avenue Nestlé 55 1800 Vevey / CH | [N/P] |
Former [2013/47] | Cogniat, Eric Jean Marie, et al Nestec S.A. CT-IAM Avenue Nestlé 55 1800 Vevey / CH | ||
Former [2013/21] | Cogniat, Eric Jean Marie, et al Nestec S.A. Avenue Nestlé 55 1800 Vevey / CH | ||
Former [2012/12] | Marquardt, Ulf Nestec S.A. IP Department Avenue Nestlé 55 1800 Vevey / CH | Application number, filing date | 10718590.2 | 07.05.2010 | WO2010EP56292 | Priority number, date | EP20090159932 | 11.05.2009 Original published format: EP 09159932 | [2012/12] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2010130661 | Date: | 18.11.2010 | Language: | EN | [2010/46] | Type: | A1 Application with search report | No.: | EP2429542 | Date: | 21.03.2012 | Language: | EN | The application published by WIPO in one of the EPO official languages on 18.11.2010 takes the place of the publication of the European patent application. | [2012/12] | Search report(s) | International search report - published on: | EP | 18.11.2010 | Classification | IPC: | A61K35/74, A23L1/30, A61P37/08, A61P1/12 | [2012/12] | CPC: |
A61K35/745 (EP,US);
A23L2/52 (EP,US);
A23L33/135 (EP,US);
A61P1/12 (EP);
A61P37/08 (EP);
A23V2002/00 (EP,US)
| C-Set: |
A23V2002/00, A23V2200/32, A23V2200/3204 (EP,US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2012/12] | Title | German: | PRÄVENTION UND BEHANDLUNG VON ALLERGISCHEM DURCHFALL | [2012/12] | English: | PREVENTION AND TREATMENT OF ALLERGIC DIARRHOEA | [2012/12] | French: | PRÉVENTION ET TRAITEMENT D'UNE DIARRHÉE ALLERGIQUE | [2012/12] | Biological material | This application mentions deposited biological material, check the file for details | Entry into regional phase | 12.12.2011 | National basic fee paid | 12.12.2011 | Designation fee(s) paid | 12.12.2011 | Examination fee paid | Examination procedure | 12.12.2011 | Examination requested [2012/12] | 22.06.2012 | Amendment by applicant (claims and/or description) | 03.12.2012 | Despatch of a communication from the examining division (Time limit: M04) | 04.04.2013 | Reply to a communication from the examining division | 02.07.2013 | Despatch of a communication from the examining division (Time limit: M02) | 09.08.2013 | Reply to a communication from the examining division | 26.09.2013 | Despatch of communication that the application is refused, reason: substantive examination [2022/08] | 13.11.2019 | Observations by third parties | 17.12.2019 | Observations by third parties | 10.12.2021 | Application refused, date of legal effect [2022/08] | Appeal following examination | 26.11.2013 | Appeal received No. T0318/14 | 31.01.2014 | Statement of grounds filed | 21.09.2021 | Invitation to file observations in an appeal (Time limit: M02) [2021/39] | 24.11.2021 | Result of appeal procedure: appeal of the applicant was rejected | 30.11.2021 | Despatch of the decision of the Board of Appeal | 07.02.2019 | Date of oral proceedings | 13.02.2019 | Minutes of oral proceedings despatched | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 03.12.2012 | Fees paid | Renewal fee | 29.03.2012 | Renewal fee patent year 03 | 10.05.2013 | Renewal fee patent year 04 | 27.03.2014 | Renewal fee patent year 05 | 12.05.2015 | Renewal fee patent year 06 | 10.05.2016 | Renewal fee patent year 07 | 10.05.2017 | Renewal fee patent year 08 | 11.05.2018 | Renewal fee patent year 09 | 15.05.2019 | Renewal fee patent year 10 | 31.03.2020 | Renewal fee patent year 11 | 13.05.2021 | Renewal fee patent year 12 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]WO2008153377 (NUTRICIA NV [NL], et al) [Y] 1-9 * page 1, line 21 - line 27 * * page 2, lines 4,5 * * page 3 - page 4 * * page 5, line 24 - line 31 * * page 18, line 8 - line 23 * * page 20, line 9 * * table 1 * * example 2 *; | [Y] - THIBAULT H ET AL, "EFFECTS OF LONG-TERM CONSUMPTION OF A FERMENTED INFANT FORMULA (WITH BIFIDOBACTERIUM BREVE C50 AND STREPTOCOCCUS THERMOPHILUS 065) ON ACUTE DIARRHEA IN HEALTHY INFANTS", JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, RAVEN PRESS, NEW YORK, NY, US, (20040801), vol. 39, no. 2, ISSN 0277-2116, pages 147 - 152, XP009043383 [Y] 1-9 * page 147, column 2 * * page 150, column 4 * * page 151, columns 4,5 * DOI: http://dx.doi.org/10.1097/00005176-200408000-00004 | [Y] - YASUI H. ET AL, "Immunomodulatory function of lactic acid bacteria", ANTONIE VAN LEEUWENHOEK, (1999), vol. 76, pages 383 - 389, XP002538609 [Y] 1-9 * page 383, columns 3,4 * * page 384, column 3 * * page 386, columns 1,2,3 * * page 388, columns 2,3,5 * DOI: http://dx.doi.org/10.1023/A:1002041616085 | [Y] - HE F ET AL, "Comparison of mucosal adhesion and species identification of bifidobacteria isolated from healthy and allergic infants", FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, (2001), vol. 30, pages 43 - 47, XP002538610 [Y] 1-9 * page 43, column 2 * * page 45, columns 2,3 * * page 46, column 3 * DOI: http://dx.doi.org/10.1111/j.1574-695X.2001.tb01548.x | [A] - MARTEAU P R, "PROBIOTICS IN CLINICAL CONDITIONS", CLINICAL REVIEWS IN ALLERGY AND IMMUNOLOGY, HUMANA PRESS, TOTOWA, NJ, US, (20020101), vol. 22, no. 3, ISSN 1080-0549, pages 255 - 273, XP009027205 [A] 1-9 * the whole document * DOI: http://dx.doi.org/10.1385/CRIAI:22:3:255 | by applicant | - SAAVEDRA ET AL., THE LANCET, (1994), vol. 344, page 1046 | - THIBAULT ET AL., J PED GASTRO NUTR, (2004), vol. 39, page 147 | - RONA, R.J. ET AL., J. ALLERGY CLIN. IMMUNOL., (2007), vol. 120, pages 638 - 646 | - BRANDT B.B ET AL., JCI, (2003), vol. 112, no. 11, pages 1666 - 1667 | - SALMINEN S; OUWEHAND A.; BENNO Y. ET AL., "Probiotics: how should they be defined", TRENDS FOOD SCI. TECHNOL., (1939), vol. 10, pages 107 - 10, XP055150446 | - GLENN R. GIBSON; MARCEL B, "Roberfroid, Dietary Modulation of the Human Colonic Microbiota: Introducing the Concept of Prebiotics", J. NUTR., (1995), vol. 125, pages 1401 - 1412 |